U.S. Markets closed

Exelixis Rises as Fourth-Quarter Earnings Beat Estimates

M. Corey Goldman

The company reports fourth-quarter earnings above analysts' forecasts amid strong revenue from collaboration agreements and royalty payments to distribute its drugs.